Table 3

HLA-DR allele frequency in patients with interferon treatment–related type 1 diabetes, classic type 1 diabetes, and healthy control subjects

Interferon treatment–related type 1 diabetic patientsClassical type 1 diabetic patientsControl subjectsInterferon treatment vs. controlInterferon treatment vs. classical type 1 diabetes
POR95% CIPOR95% CI
n130384608
DR14.6 (6)2.1 (8)5.6 (34)
DR434.6 (45)38.0 (146)22.4 (136)<0.011.841.22–2.77
DR87.7 (10)9.9 (38)15.3 (93)<0.050.460.23–0.91
DR926.9 (35)29.4 (113)16.4 (100)<0.011.871.20–2.92
DR121.5 (2)3.4 (13)5.1 (31)
DR1315.4 (20)7.8 (30)4.3 (26)<0.00013.802.20–7.55<0.052.151.17–3.93
DR146.9 (9)0.5 (2)8.6 (52)<0.000114.23.03–66.7
DR152.3 (3)4.7 (18)17.8 (108)<0.00010.080.03–0.35
Others0 (0)4.2 (16)4.6 (28)
  • Data are % (n) unless otherwise indicated.